Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.

Autor: Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation. tsaurga@mis66.ru.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation. tsaurga@mis66.ru.; Ural State Medical University, Ekaterinburg, Russian Federation. tsaurga@mis66.ru., Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Shorikov E; PET-Technology Center of Nuclear Medicine, Ekaterinburg, Russian Federation., Makarova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Zhukova Y; Regional Children's Hospital, Ekaterinburg, Russian Federation., Arakaev O; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Riger T; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Solodovnikov A; Ural State Medical University, Ekaterinburg, Russian Federation., Lapotentova E; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Aleinikova O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Myakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Boichenko E; City Children's Hospital №1, Saint-Petersburg, Russian Federation., Kondratchik K; Morozov Children's Hospital, Moscow, Russian Federation., Nikonova O; Regional Children's Clinical Hospital, Perm, Russian Federation., Shapochnik A; Orenburg Regional Clinical Oncology Center, Orenburg, Russian Federation., Goroshkova M; Kuzbass Children's Clinical Hospital, Novokuznetsk, Russian Federation., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Roumiantsev A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Jazyk: angličtina
Zdroj: Leukemia [Leukemia] 2023 Nov; Vol. 37 (11), pp. 2276-2281. Date of Electronic Publication: 2023 Sep 23.
DOI: 10.1038/s41375-023-02034-4
Databáze: MEDLINE